Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Madrigal Pharmaceuticals Inc (MDGL)

Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Is Madrigal Pharmaceuticals Stock a Buy?

The biotech could be worth a lot more in 10 years.

NVO : 127.51 (-5.46%)
LLY : 921.49 (+0.70%)
MDGL : 233.49 (-3.62%)
This 1 Setback for Novo Nordisk Is Bullish for Madrigal Pharmaceuticals Stock

One player's minor pain is another's moderate gain.

MDGL : 233.49 (-3.62%)
NVO : 127.51 (-5.46%)
Madrigal: Q2 Earnings Snapshot

Madrigal: Q2 Earnings Snapshot

MDGL : 233.49 (-3.62%)
Is It Too Late to Buy Madrigal Pharmaceuticals Stock?

Will being the first to its market ensure that its future is bright?

MDGL : 233.49 (-3.62%)
Is Madrigal Pharmaceuticals a Millionaire Maker?

Its revenue ramp-up is just starting, and its market looks lucrative.

MDGL : 233.49 (-3.62%)
Is Madrigal Pharmaceuticals Stock a Buy?

The company could become a prominent player in the biotech industry, but that might take a while.

MDGL : 233.49 (-3.62%)
The Best Biotech Stock to Invest $1,000 in Right Now

This stock may not be a slam dunk, but it's looking very promising.

MDGL : 233.49 (-3.62%)
LLY : 921.49 (+0.70%)
NVO : 127.51 (-5.46%)
VKTX : 70.47 (+3.39%)
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.

Eli Lilly just drizzled on Madrigal Pharmaceuticals' parade.

MDGL : 233.49 (-3.62%)
LLY : 921.49 (+0.70%)
Where Will Madrigal Pharmaceuticals Be in 3 Years?

The coast is clear for it to grow, for now.

MDGL : 233.49 (-3.62%)
NVO : 127.51 (-5.46%)
Better Biotech Stock: Viking Therapeutics vs. Madrigal Pharmaceuticals

Success isn't guaranteed, but both companies could become big winners.

VKTX : 70.47 (+3.39%)
MDGL : 233.49 (-3.62%)

Barchart Exclusives

3 Dividend Kings With Unstoppable Dividend Growth Potential
Discover three quality companies with healthy financials, low dividend payout ratios, and a history of incredible dividend growth. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar